News Agency
The Times

A Treatment Option for Metastatic Colorectal Cancer Patients with BRAFV600E Mutation in Singapore

  • Written by Media Outreach

Targeted therapy regimen, BRAFTOVI® (encorafenib) in combination with cetuximab, included on MOH Cancer Drug List, for the treatment of adult patients with BRAFV600E-mutant metastatic colorectal cancer who have received prior systemic therapy.

SUMMARY OF KEY POINTS
  • BRAFTOVI in combination with cetuximab has been included on MOH CDL, for...

Read more: A Treatment Option for Metastatic Colorectal Cancer Patients with BRAFV600E Mutation in Singapore

Google Ads Agency Sydney: How to Generate More Qualified Leads With Paid Search

When someone searches Google for a service they need immediately, appearing at the right moment can be extremely valuable. Unlike many traditional marketing channels, paid search can place a business in front of people who are already researching a product... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion